Imposter Zoster: An Atypical Case of Varicella-Zoster Virus Infection

被引:1
|
作者
Dhaliwal, Galvin [1 ]
Mirza, Waqqas [2 ]
Coralde, John M. Vincent [2 ]
Dhillon, Jaspreet [1 ]
Patel, Taral [3 ]
机构
[1] Southwest Healthcare Med Educ Consortium, Internal Med, Temecula, CA 31720 USA
[2] Southern Calif Med Educ Consortium, Internal Med, Temecula, CA USA
[3] Southwest Healthcare Med Educ Consortium, Internal Med, Corona, CA USA
关键词
antivirals; geriatrics; vaccination; visceral pain; polymerase chain reaction; high-value care; postherpetic neuralgia; abdominal pain; shingles; varicella zoster;
D O I
10.7759/cureus.42104
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this report, we describe a case involving an 80-year-old female who presented to the emergency department with an acute onset of left upper quadrant abdominal pain. The chief complaint misled us down multiple pathways of considering ischemic bowel disease, peptic ulcer disease, and small bowel obstruction. As a result, this led to costly and invasive diagnostic studies. However, the actual cause eventually became apparent -a cutaneous varicella-zoster virus infection.This case underscores the significance of maintaining a comprehensive list of potential diagnoses, particularly in elderly adults who commonly present atypically and often face difficulty expressing their symptoms. It also underlines the diagnostic challenges associated with identifying shingles without cutaneous findings. Early detection is crucial in preventing unnecessary tests, minimizing costs, and avoiding treatment delays. Furthermore, the case is a powerful example of the importance of vaccination, which has been proven to be 68-97% effective in preventing shingles and postherpetic neuralgia, depending on the individual's immune function.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] VARICELLA-ZOSTER VIRUS VACCINE, SUCCESSES AND DIFFICULTIES
    Sarkadi, Julia
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2013, 60 (04) : 379 - 396
  • [32] Herpes zoster after varicella-zoster vaccination
    Fahlbusch, M.
    Wesselmann, U.
    Lehmann, P.
    HAUTARZT, 2013, 64 (02): : 107 - 109
  • [33] Seroprevalence of varicella-zoster virus in the German population
    Wutzler, P
    Färber, I
    Wagenpfeil, S
    Bisanz, H
    Tischer, A
    VACCINE, 2001, 20 (1-2) : 121 - 124
  • [34] Guillain-Barré syndrome following varicella-zoster virus infection
    Badrul Islam
    Zhahirul Islam
    Corine H. GeurtsvanKessel
    Israt Jahan
    Hubert P. Endtz
    Quazi D. Mohammad
    Bart C. Jacobs
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 511 - 518
  • [35] Recent Issues in Varicella-Zoster Virus Latency
    Kennedy, Peter G. E.
    Mogensen, Trine H.
    Cohrs, Randall J.
    VIRUSES-BASEL, 2021, 13 (10):
  • [37] Detection of varicella-zoster virus DNA in cerebrospinal fluid in an infant with herpes zoster
    Ishikawa, Kei
    Irimada, Takeshi
    Anzo, Makoto
    Kinai, Ei
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [38] Varicella-zoster virus-related neurological complications: From infection to immunomodulatory therapies
    Hakami, Mohammed Ageeli
    Khan, Farhan R.
    Abdulaziz, Osama
    Alshaghdali, Khalid
    Hazazi, Ali
    Aleissi, Awad F.
    Abalkhail, Adil
    Alotaibi, Bader S.
    Alhazmi, Abdulfattah Yahya M.
    Kukreti, Neelima
    Binshaya, Abdulkarim S.
    REVIEWS IN MEDICAL VIROLOGY, 2024, 34 (04)
  • [39] Periodicity of varicella-zoster virus in the presence of immune boosting and clinical reinfection with varicella
    Korostil, Igor A.
    Wood, James G.
    Regan, David G.
    THEORETICAL BIOLOGY AND MEDICAL MODELLING, 2015, 12
  • [40] Preventing Varicella-Zoster: Advances With the Recombinant Zoster Vaccine
    Ilyas, Sahrish
    Chandrasekar, Pranatharthi H.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (07):